Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Foundational ingredients of robotic gait training for people with incomplete spinal cord injury during inpatient rehabilitation (FIRST): A randomized controlled trial protocol

  • Chad Swank,

    Roles Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

    Affiliations Baylor Scott and White Research Institute, Dallas, Texas, United States of America, Baylor Scott & White Institute for Rehabilitation, Dallas, Texas, United States of America

  • Alexandria Holden ,

    Roles Project administration, Writing – original draft, Writing – review & editing

    Alexandria.Holden@BSWHealth.org

    Affiliation Baylor Scott and White Research Institute, Dallas, Texas, United States of America

  • Lacy McDonald,

    Roles Project administration, Writing – original draft, Writing – review & editing

    Affiliation Baylor Scott and White Research Institute, Dallas, Texas, United States of America

  • Simon Driver,

    Roles Conceptualization, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing

    Affiliation Baylor Scott and White Research Institute, Dallas, Texas, United States of America

  • Librada Callender,

    Roles Project administration, Writing – original draft, Writing – review & editing

    Affiliation Baylor Scott and White Research Institute, Dallas, Texas, United States of America

  • Monica Bennett,

    Roles Formal analysis, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Baylor Scott & White Health, Dallas, Texas, United States of America

  • Seema Sikka

    Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing

    Affiliations Baylor Scott & White Institute for Rehabilitation, Dallas, Texas, United States of America, Baylor Scott & White Health, Dallas, Texas, United States of America

Abstract

Introduction

As technological advances allow the use of robotic exoskeleton devices with gait training, there is a critical need to establish a robotic gait training (RGT) program to meet the needs of people with spinal cord injury (SCI) during inpatient rehabilitation. The purposes of this study are to prospectively examine the efficacy of a stakeholder informed RGT program compared to usual care gait training (UC) during inpatient rehabilitation in people with incomplete SCI and compare the intensity of RGT and UC gait training during inpatient rehabilitation.

Study design

128 patients with incomplete SCI admitted to our inpatient rehabilitation facility will be screened for eligibility and randomized to either the RGT or UC group. RGT sessions will use the Ekso robotic exoskeleton [class II medical device (United States FDA)]. UC sessions will use traditional gait training approaches such as manually assisted overground gait training with walkers and orthotics and body weight–supported treadmill training (BWSTT). Our primary outcome is gait function as characterized by the Walking Index for Spinal Cord Injury–II (WISCI-II). Secondary outcomes are gait speed, Spinal Cord Independence Measure (SCIM), Numeric Pain Rating Scale (NPRS), Fatigue Severity Scale (FSS), Penn Spasm Frequency Scale (PSFS), Patient Health Questionnaire-9 (PHQ-9), General Anxiety Disorder– 7 (GAD-7), International Spinal Cord Injury Quality of Life Basic Data Set, and a Qualitative Questionnaire. Assessments of primary and secondary outcomes will occur at admission and discharge from inpatient rehabilitation. General or generalized linear models will be used to analyze differences between groups for all measures.

Clinical impact

Successful completion of this study will provide a usable, replicable, stakeholder informed RGT intervention for use with individuals with incomplete SCI during inpatient rehabilitation.

Introduction

Spinal cord injury (SCI) due to trauma is estimated to affect 288,000–500,000 Americans, with about 17,700 new cases annually [1]. Despite general advances in medicine, the average life expectancy for persons with SCI has remained largely unchanged since the 1980s and are significantly lower than for persons without SCI [2, 3]. Given this disparity of life expectancy and decreased quality of life after SCI [4], gait training has the opportunity to positively impact the lives of people after SCI. Not surprisingly, recovery of walking is a primary rehabilitation goal for patients and encouraged by therapists [5, 6] due to its relationship to quality of life [7, 8]. impact on health, psychological profile [9], and social participation after SCI [10, 11].

Advances in technology are being adopted into clinical rehabilitation practice at a rapid pace. Robotic exoskeletons (wearable robots to enhance overground mobility) are a potentially viable technology that can be used for gait training among those with acute SCI. Yet, foundational evidence to support exoskeleton use during the acute phase of recovery is lacking. While robotic exoskeleton technology is not yet mature enough to produce independent community ambulation [12, 13], the technology has improved [14] and may allow for enhanced SCI rehabilitation [15].

Today four FDA-approved exoskeleton devices are commercially available that allow people to step over-ground using variable levels of assist depending on the individual’s ability [13]. The contemporary robotic exoskeleton is a rechargeable bionic device worn over the lower extremities with motorized joints that can provide externally-powered gait independent of a treadmill system [16] and allow repetitive task specific movement training [15]. The focus of this protocol was the use of an exoskeleton to enhance recovery of gait through over-ground repetitive task specific movement. This protocol paper followed the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist to report relevant clinical trial details as recommended by the EQUATOR Network (Enhancing the Quality and Transparency of Health Research).

Objectives and aims

Aim 1: Develop a robotic gait training (RGT) program that meets the unique needs of people after incomplete SCI during inpatient rehabilitation.

  1. Hypothesis 1.1: Engage key stakeholders (patients, caregivers, clinicians, researchers, industry members) in a community-based participatory research approach to develop the content and structure of the RGT program to accommodate current clinical practice guidelines and integrate emerging robotic exoskeleton technology.

Aim 2: Examine the efficacy of RGT compared to usual care gait training (UC) during inpatient rehabilitation in people with incomplete SCI.

  1. Hypothesis 2.1: Patients with incomplete SCI who receive RGT will have higher walking function (Walking Index for Spinal Cord Injury–Revised (WISCI-II)) at discharge compared to UC.
  2. Hypothesis 2.2: Patients with incomplete SCI who receive RGT will have greater improvement in secondary outcomes (gait speed, daily functional independence, pain, fatigue, spasm frequency, depressive symptoms, and quality of life) at discharge compared to UC.

Aim 3: Compare the intensity of RGT and UC gait training during inpatient rehabilitation. Intensity data will include (1) heart rate, (2) rate of perceived exertion (RPE), and (3) number of steps.

  1. Hypothesis 3.1: RGT will be of significantly greater intensity with participants (1) spending more minutes per session and total minutes (over all sessions) in moderate intensity exercise (40% to 60% range of heart rate reserve), (2) reporting higher mean RPE across all sessions, and (3) completing more steps during each session and total number of steps over all sessions compared to UC.
  2. Hypothesis 3.2: Intensity will be significantly correlated to the primary outcome (WISCI-II) for the RGT and UC groups.

Methods

Study design

This is a prospective randomized controlled trial. Participants will be randomly assigned to one of two groups: RGT or UC. This study has been registered on ClinicalTrials.gov (Registration number: NCT04781621) and was approved by an Institutional Review Board (020–483). The intervention design and timeline are outlined in Fig 1.

Study setting

This study will take place at a large rehabilitation hospital in an urban setting in the southwestern United States between April 2021 and August 2023. The rehabilitation hospital is accredited by The Joint Commission.

Participants and recruitment

All patients with incomplete SCI will be screened at admission to inpatient rehabilitation at for initial eligibility.

Screening and patient suitability will be discussed at the twice weekly SCI clinical team rounding meeting. Study staff will approach identified individuals who meet the inclusion/exclusion criteria during the first 7 days in a private setting and briefly explain the study and answer any patient questions for clarification. Caregivers can consent to study on behalf of minors and minors will be given an opportunity to assent to project.

Eligibility

Patients will be screened at admission for initial eligibility and qualifying patients will be approached to participate. Individuals between the ages of 16 to 85 years within six months post-incomplete SCI who are admitted to inpatient rehabilitation and who meet criteria to use a robotic exoskeleton will be recruited to participate in this study. Patients must meet manufacturer robotic exoskeleton frame limitations including weigh 100 kilograms or less; between 1.52 meters and 1.92 meters tall; have a standing hip width of 45.72 centimeters or less; have near normal range of motion in hips, knees, and ankles; able to attain a neutral ankle dorsiflexion with < 12 degrees of knee flexion; no more than 12 degree hip flexion contracture; no upper leg length discrepancy greater than 1.27 centimeters or lower leg discrepancy greater than 1.91 centimeters.

Exclusion criteria are as follows: (1) moderate to severe TBI, (2) degenerative diagnoses, (3) wound located in proximity to the exoskeleton frame, (4) severe osteoporosis/-penia as shown with DXA, (5) pre-morbid developmental disability, significant psychological diagnosis, or other cognitive impairment.

Patients will be evaluated by clinicians to determine if they meet the inclusion/exclusion criteria during their inpatient stay. If a patient is not initially appropriate for intervention due to medical reasons and later determined to appropriate during their stay, they may be approached to consent to participate.

Intervention

Each patient with SCI enrolled in this study (both RGT and UC groups) will be provided with standard of care inpatient rehabilitation services. Patients who are admitted must be able to tolerate 3 hours of intense rehabilitation services per day [17]. During inpatient rehabilitation, and to meet CMS requirements [17], the dose for Inpatient Physical Therapy Services will be 90 minutes per day for 5 days per week of physical therapy, which is consistent with nationally recognized inpatient rehabilitation. The content of inpatient physical therapy services, individualized to participants’ needs based on level of function and medical need, may include basic mobility training (e.g., bed mobility, transfers), stretching and strengthening exercises, gait training (e.g., BWSTT, overground with braces), and wheelchair mobility. Therapeutic approaches follow both current SCI-specific clinical practice guidelines for rehabilitation and involve using only those approaches identified in a recent systematic review of 22 common therapeutic approaches for SCI as effective [18]. Refer to Table 1 for a sample schedule for physical therapy during inpatient rehabilitation.

thumbnail
Table 1. Sample schedule for physical therapy treatment: Usual care and RGT (in minutes).

https://doi.org/10.1371/journal.pone.0267013.t001

Both Treatment Groups receive equal dosage of recommended physical therapy approaches. Gait training for the UC group will consist of body weight–supported treadmill training (BWSTT) and conventional overground walking for 90 minutes a week. Gait training for RGT group will include 90 minutes of RGT a week. Each participant will engage in an intervention of gait training. Patients will participate for the duration of their length of stay for inpatient rehabilitation, from the time they consent after admission to the time they discharge.

Outcome measures

Assessments will be conducted at admission, discharge and during the treatment intervention. Table 1 shows the patient event timeline for outcomes evaluated at different time points. The following demographic data is collected at admission: current age and age at injury; injury severity; gender; ethnicity; education level; pre-morbid history of mental illness; residence status; income; insurance type; vocation; financial status and ASIA Impairment Scale (AIS) score.

The primary and secondary outcome measures are listed in Table 2. The 10MWT, WISCI-II, SCIM, NPRS, and PSFS assessments will be assessed by a licensed clinician. Patients will complete the following self-reported assessments with a blinded research staff: FSS, PHQ-9, GAD-7, GAD-7 and Qualitative Questionnaire. After each treatment intervention, heart rate (HR) and number of steps will be collected from devices (Polar Watch, Pedometer, and EKSO) worn by patient and self-reported rating of perceived exertion (RPE).

thumbnail
Table 2. Outcome measures for proposed project and link to ICF.

https://doi.org/10.1371/journal.pone.0267013.t002

Sample size

Sample size calculations were performed to determine the required sample size in each group based on detectable effect size. For 80% power with a 5% significance level, 64 participants will be enrolled in each group (n = 128 total) to detect a medium effect size of 0.5 and allow for ~10% attrition due to unplanned medical events, acute care transfers, and patient withdrawals. All analysis will be performed using SAS 9.4 significance set at the 5% level.

Allocation

Participants will be randomized using cluster randomization based on the characteristic of level of injury (incomplete tetraplegia and incomplete paraplegia) for stratified block. Within each strata randomization blocks of size 6 will be used to ensure equal distribution between groups. The randomization scheme will be generated by the biostatistician, with the randomization scheme uploaded into the REDCap database by an unblinded data analyst.

Data management, quality assurance, and exclusion of bias

Data management functions will occur on a quarterly basis and will include data quality checks and verification, as well as internal edit and logic checks (e.g., out of range values, internal inconsistencies). Ten percent of charts will be audited for source document and data entry review. Cross tabulation checks using SAS will also be used. Data will be stored and backed-up periodically on the biostatistician’s space on the secure server. Descriptive statistics will be at calculated and included into quarterly reports for a Data Safety and Monitoring Board to ensure the quality of data and progress of the study. In addition, a quality assurance coordinator independent of the study execution will conduct a quality assurance review at beginning of enrollment, midpoint and end of the study.

A detailed Data and Safety Monitoring Plan will be submitted to the IRB. The study staff will be responsible for collecting and recording all clinical data. As results are collected, all Adverse Events will be identified, graded for severity and assigned causality, reported to the required entities, and compiled for periodic review. To protect confidentiality, all subjects will be given unique subject IDs which will be used for all study documentation. All dates will be calculated and identifiers will be deleted. Links to identifiers will be kept on a secure server in a separate password-protected file and will only be available to study personnel. All study data will be input into REDCap database which is a secure, HIPAA-compliant web application to manage research data. No identifying information will be used for statistical analyses. All scientific data will be submitted to ICPSR per ACL/NIDILRR guidelines following the completion of the study.

Given the type of intervention, participants will not be blinded to group assignment. However, to minimize assessor bias, outcome assessments will be conducted by blinded research staff.

Statistical methods

Aim 1: Develop an RGT program that meets the unique needs of people after incomplete SCI during inpatient rehabilitation.

Aim 1 Analysis. Engagement of the Advisory Board in development of the RGT program and recommendations throughout the 3-year study will be qualitatively described.

Aim 2: Examine the efficacy of RGT compared to UC gait training during inpatient rehabilitation in people with incomplete SCI.

Aim 2 Analysis. All analysis will be performed using SAS 9.4 with a significance level of 0.05. To determine if patients with incomplete SCI who receive RGT will have higher walking function than UC at discharge (Hypothesis 2.1), WISCI-II scores will be evaluated using a linear model. The distribution of WISCI-II scores will be assessed to determine if a general linear model will be utilized, or if a generalized linear model with an alternative distribution and link function, such as the gamma distribution with a log link, will be more appropriate. Similarly, all measures associated with the secondary outcomes in Hypothesis 2.2 (10MWT, SCIM, NPRS, FSS, PSFS, PHQ-9, GAD-7, and International SCI Quality of Life Basic Data Set Qualitative Questionnaire) will be evaluated with general or generalized linear models, as appropriate. A separate model will be run for each outcome. All models for both the primary and secondary outcomes will control for scores at admission as well as the patient’s demographic and impairment information listed in section B.1.i.D.

Aim 3: Compare the intensity of RGT and UC gait training during inpatient rehabilitation. Intensity data will include (1) heart rate, (2) RPE, and (3) number of steps.

Aim 3 Analysis: Moderate heart rate intensity minutes, average RPE, and steps will be evaluated using individual general or generalized linear models, as appropriate, to determine the association between RGT and UC and intensity. Each model will control for the patient characteristics and total number of sessions. Additionally, to determine the relationship between session intensity and walking function correlation coefficients will be calculated between each intensity measure and WISCI-II at admission, discharge, and change score.

For both Aims 2 and 3 stratified subset analysis will be performed for tetraplegia and paraplegia to determine if RGT has a differing impact depending on injury classification.

If a patient misses an assessment, their data for that outcome will be treated as missing and will not be included in the statistical model. However, the data from the completed assessments for that patient will be included. Sensitivity analysis will be performed to assess the impact of missing data, by imputing a missing outcome measure using the overall average change score for the given outcome. The sensitivity analyses will be compared to the initial analysis to determine the impact of missingness on the results.

Discussion

The ability to walk is a priority for people with SCI [42] particularly among those newly injured. While there is great interest in the potential of pharmacological, biological, and genetic interventions to improve walking function in persons with SCI [43], the efficacy of these approaches has not yet been established. A recent systematic review of strategies to improve motor function in persons with SCI concluded that gait training is a necessary component for recovering walking function in multi-intervention approaches [43]. However, the most effective gait training approach for people with SCI remains unclear. The overarching goal of this protocol is to address walking recovery among those with SCI during inpatient rehabilitation by developing and evaluating an inpatient rehabilitation RGT program for people with SCI when the neuroplasticity potential is greatest [44]. The study offers a foundational step in establishing a stakeholder-informed clinical protocol for RGT use in this setting and evidence of the effectiveness of the approach compared to usual care. This study will yield evidence about the clinical use and effectiveness of a stakeholder informed RGT program during inpatient rehabilitation for people with incomplete SCI. Study findings will be disseminated through patient and clinician centered fact sheets, scientific conferences, and peer-reviewed publications.

References

  1. 1. National Spinal Cord Injury Statistical Center. Facts and Figures at a Glance 2018 [Available from: https://www.nscisc.uab.edu
  2. 2. Savic G, DeVivo MJ, Frankel HL, Jamous MA, Soni BM, Charlifue S. Long-term survival after traumatic spinal cord injury: a 70-year British study. Spinal cord. 2017;55(7):651–8. pmid:28290467
  3. 3. Shavelle RM, DeVivo MJ, Brooks JC, Strauss DJ, Paculdo DR. Improvements in long-term survival after spinal cord injury? Arch Phys Med Rehabil. 2015;96(4):645–51. pmid:25616394
  4. 4. Dijkers M. Quality of life after spinal cord injury: a meta analysis of the effects of disablement components. Spinal cord. 1997;35(12):829. pmid:9429262
  5. 5. Fleerkotte BM, Koopman B, Buurke JH, van Asseldonk EH, van der Kooij H, Rietman JS. The effect of impedance-controlled robotic gait training on walking ability and quality in individuals with chronic incomplete spinal cord injury: an explorative study. Journal of neuroengineering and rehabilitation. 2014;11(1):1.
  6. 6. van Middendorp JJ, Hosman AJF, Van de Meent H. Who wants to walk? Preferences for recovery after SCI: a longitudinal and cross-sectional study. Spinal Cord. 2009;47(3):268. pmid:18936769
  7. 7. Bogey R, George Hornby T. Gait training strategies utilized in poststroke rehabilitation: are we really making a difference? Topics in Stroke Rehabilitation. 2007;14(6):1. pmid:18171655
  8. 8. Buzzelli S, Di Francesco L, Villani S, Giaquinto S. Gait in stabilized hemiplegic outpatients in rehabilitation. Disability and rehabilitation. 2003;25(17):964–7. pmid:12851084
  9. 9. Saadat S, Javadi M, Divshali BS, Tavakoli AH, Ghodsi SM, Montazeri A, et al. Health-related quality of life among individuals with long-standing spinal cord injury: a comparative study of veterans and non-veterans. BMC Public Health. 2010;10(1):6. pmid:20047697
  10. 10. Semerjian T, Montague S, Dominguez J, Davidian A, de Leon R. Enhancement of quality of life and body satisfaction through the use of adapted exercise devices for individuals with spinal cord injuries. Topics in spinal cord injury rehabilitation. 2005;11(2):95–108.
  11. 11. Hicks AL, Adams MM, Ginis KM, Giangregorio L, Latimer A, Phillips SM, et al. Long-term body-weight-supported treadmill training and subsequent follow-up in persons with chronic SCI: effects on functional walking ability and measures of subjective well-being. Spinal Cord. 2005;43(5):291. pmid:15685260
  12. 12. del-Ama AJ, Gil-Agudo Á, Pons JL, Moreno JC. Hybrid gait training with an overground robot for people with incomplete spinal cord injury: a pilot study. Frontiers in human neuroscience. 2014;8. pmid:24860478
  13. 13. Lajeunesse V, Vincent C, Routhier F, Careau E, Michaud F. Exoskeletons’ design and usefulness evidence according to a systematic review of lower limb exoskeletons used for functional mobility by people with spinal cord injury. Disability and Rehabilitation: Assistive Technology. 2016;11(7):535. pmid:26340538
  14. 14. Holanda LJ, Silva PM, Amorim TC, Lacerda MO, Simão CR, Morya E. Robotic assisted gait as a tool for rehabilitation of individuals with spinal cord injury: a systematic review. Journal of neuroengineering and rehabilitation. 2017;14(1):126. pmid:29202845
  15. 15. Mekki M, Delgado AD, Fry A, Putrino D, Huang V. Robotic Rehabilitation and Spinal Cord Injury: a Narrative Review. Neurotherapeutics. 2018:1–14. pmid:29340930
  16. 16. Sale P, Franceschini M, Waldner A, Hesse S. Use of the robot assisted gait therapy in rehabilitation of patients with stroke and spinal cord injury. European journal of physical and rehabilitation medicine. 2012;48(1):111–21. pmid:22543557
  17. 17. Centers for Medicare & Medicaid Services. Inpatient Rehabilitation Facilities 2012 [Available from: https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/CertificationandComplianc/InpatientRehab.html
  18. 18. Harvey L, Glinsky J, Bowden J. The effectiveness of 22 commonly administered physiotherapy interventions for people with spinal cord injury: a systematic review. Spinal cord. 2016;54(11):914. pmid:27349607
  19. 19. Ditunno PL, Dittuno JF. Walking index for spinal cord injury (WISCI II): scale revision. Spinal cord. 2001;39(12):654. pmid:11781863
  20. 20. Marino RJ, Scivoletto G, Patrick M, Tamburella F, Read MS, Burns AS, et al. Walking index for spinal cord injury version 2 (WISCI-II) with repeatability of the 10-m walk time: Inter- and intrarater reliabilities. AmJPhysMedRehabil. 2010;89(1):7. pmid:20026943
  21. 21. Burns AS, Delparte JJ, Patrick M, Marino RJ, Ditunno JF. The reproducibility and convergent validity of the walking index for spinal cord injury (WISCI) in chronic spinal cord injury. NeurorehabilNeural Repair. 2011;25(2):149. pmid:21239706
  22. 22. Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. Journal of aging and physical activity. 2015;23(2):314–22. pmid:24812254
  23. 23. Jackson AB, Carnel CT, Ditunno JF, Read MS, Boninger ML, Schmeler MR, et al. Outcome measures for gait and ambulation in the spinal cord injury population. The journal of spinal cord medicine. 2008;31(5):487–99. pmid:19086706
  24. 24. Lam T, Noonan VK, Eng JJ. A systematic review of functional ambulation outcome measures in spinal cord injury. Spinal cord. 2008;46(4):246. pmid:17923844
  25. 25. Bowden MG, Behrman AL. Step Activity Monitor: accuracy and test-retest reliability in persons with incomplete spinal cord injury. Journal of rehabilitation research and development. 2007;44(3):355–62. pmid:18247232
  26. 26. Itzkovich M, Tamir A, Philo O, Steinberg F, Ronen J, Spasser R, et al. Reliability of the Catz-Itzkovich Spinal Cord Independence Measure assessment by interview and comparison with observation. American journal of physical medicine & rehabilitation. 2003;82(4):267. pmid:12649651
  27. 27. Catz A, Itzkovich M, Agranov E, Ring H, Tamir A. SCIM-spinal cord independence measure: a new disability scale for patients with spinal cord lesions. Spinal cord. 1997;35(12):850. pmid:9429264
  28. 28. Bryce TN, Budh CN, Cardenas DD, Dijkers M, Felix ER, Finnerup NB, et al. Pain after spinal cord injury: an evidence-based review for clinical practice and research. Report of the National Institute on Disability and Rehabilitation Research Spinal Cord Injury Measures meeting. The journal of spinal cord medicine. 2007;30(5):421–40. pmid:18092558
  29. 29. Hanley MA, Masedo A, Jensen MP, Cardenas D, Turner JA. Pain interference in persons with spinal cord injury: classification of mild, moderate, and severe pain. The journal of pain: official journal of the American Pain Society. 2006;7(2):129–33.
  30. 30. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. Journal of psychosomatic research. 2004;56(2):157–70. pmid:15016573
  31. 31. Anton HA, Miller WC, Townson AF. Measuring fatigue in persons with spinal cord injury. Archives of physical medicine and rehabilitation. 2008;89(3):538–42. pmid:18295634
  32. 32. Hsieh J, Wolfe D, Miller W, Curt A. Spasticity outcome measures in spinal cord injury: psychometric properties and clinical utility. Spinal cord. 2008;46(2):86. pmid:17909559
  33. 33. Priebe MM, Sherwood AM, Thornby JI, Kharas NF, Markowski J. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem. Archives of physical medicine rehabilitation. 1996;77(7):713–6. pmid:8670001
  34. 34. Bombardier CH, Richards JS, Krause JS, Tulsky D, Tate DG. Symptoms of major depression in people with spinal cord injury: implications for screening. Archives of physical medicine rehabilitation. 2004;85(11):1749–56. pmid:15520969
  35. 35. Krause JS, Saunders LL, Reed KS, Coker J, Zhai Y, Johnson E. Comparison of the Patient Health Questionnaire and the Older Adult Health and Mood Questionnaire for self-reported depressive symptoms after spinal cord injury. Rehabilitation psychology. 2009;54(4):440. pmid:19929126
  36. 36. Anke AG, Fugl-Meyer AR. Life satisfaction several years after severe multiple trauma–a retrospective investigation. Clinical rehabilitation. 2003;17(4):431–42. pmid:12785252
  37. 37. van Koppenhagen CF, Post MW, van der Woude LH, de Witte LP, van Asbeck FW, de Groot S, et al. Changes and determinants of life satisfaction after spinal cord injury: a cohort study in the Netherlands. ArchPhysMedRehabil. 2008;89(9):1733. pmid:18675395
  38. 38. Borg GA. Psychophysical bases of perceived exertion. Med sci sports exerc. 1982;14(5):377. pmid:7154893
  39. 39. Chen MJ, Fan X, Moe ST. Criterion-related validity of the Borg ratings of perceived exertion scale in healthy individuals: a meta-analysis. Journal of sports sciences. 2002;20(11):873–99. pmid:12430990
  40. 40. Yang JF, Musselman KE, Livingstone D, Brunton K, Hendricks G, Hill D, et al. Repetitive mass practice or focused precise practice for retraining walking after incomplete spinal cord injury? A pilot randomized clinical trial. Neurorehabilitation and neural repair. 2014;28(4):314–24. pmid:24213960
  41. 41. Holleran CL, Hennessey PW, Leddy AL, Mahtani GB, Brazg G, Schmit BD, et al. High-Intensity Variable Stepping Training in Patients With Motor Incomplete Spinal Cord Injury: A Case Series. Journal of Neurologic Physical Therapy. 2018;42(2):94–101. pmid:29547484
  42. 42. Ditunno P, Patrick M, Stineman M, Ditunno J. Who wants to walk? Preferences for recovery after SCI: a longitudinal and cross-sectional study. Spinal cord. 2008;46(7):500–6. pmid:18209742
  43. 43. Gomes-Osman J, Cortes M, Guest J, Pascual-Leone A. A systematic review of experimental strategies aimed at improving motor function after acute and chronic spinal cord injury. Journal of neurotrauma. 2016;33(5):425–38. pmid:26415105
  44. 44. Buurke JH, Nene AV, Kwakkel G, Erren-Wolters V, Ijzerman MJ, Hermens HJ. Recovery of gait after stroke: what changes? NeurorehabilNeural Repair. 2008;22(6):676. pmid:18971383